Source: Own Snap
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Quantum eMotion (QNC) has signed a broad commercial and technical agreement with Greybox Solutions of Montreal
  • The agreement establishes QeM as Greybox’s cybersecurity partner
  • Quantum eMotion focuses on developing a new generation of quantum-safe encryption for the quantum computing age
  • Quantum Emotion Corp. (QNC) is up 9.52 per cent, trading at C$0.115 per share at 2:36 pm ET

Quantum eMotion (QNC) has signed a broad commercial and technical agreement with Greybox Solutions of Montreal.

This partnership will enable Greybox’s Digital Therapeutic product to take advantage of QeM’s Quantum-Safe cryptographic platform.

Greybox Solutions is a health technology company specializing in innovative software development to improve patients’ lives. Its mission is to find digital transformation solutions to address healthcare system challenges and reduce the burden of managing chronic illnesses.

The agreement establishes QeM as Greybox’s cybersecurity partner. This collaboration will integrate and promote QeM’s cybersecurity technology with Greybox’s TakeCare product. It will help health professionals and patients manage their treatment plans at home to reduce hospital readmissions and improve health outcomes.

Digital Therapeutics refers to the use of technology-driven solutions, such as mobile apps, wearable devices, and telemedicine. It delivers evidence-based interventions for the prevention, management, and treatment of various medical conditions.

Quantum eMotion focuses on developing a new generation of quantum-safe encryption for the quantum computing age. Its mission is to address the growing demand for affordable hardware security for connected devices.

Quantum Emotion Corp. (QNC) is up 9.52 per cent, trading at C$0.115 per share at 2:36 pm ET.


More From The Market Herald
The Market Herald Video

" Datametrex (TSXV:DM) details exciting initiatives ahead

Datametrex (DM) has issued a corporate update as of March 2023.

" Innocan Pharma (CSE:INNO) reports successful efficacy test for vaginal derma product

Innocan Pharma (INNO) has announced successful results from a controlled efficacy test of its vaginal derma product.

" @ the Bell: TSX bounces back again

Euro banking drama had a ripple effect felt on Bay Street Friday but Canada’s main stock index dodged another close in the red.
RBC

" Survey shows fraud risk a rising concern for Canadians

Latest survey by Royal Bank of Canada shows Canadians are concerned about spotting scams and that fraud risk will get worse if a recession